NCT05198141 (letrezole) is a Phase 4 clinical trial of Letrozole tablets in Ectopic Pregnancy, sponsored by Zagazig University.

Who is sponsoring NCT05198141?

NCT05198141 is sponsored by Zagazig University.

What drugs are being tested in NCT05198141?

Interventions in NCT05198141: Letrozole tablets, laparoscopic salpingectomy.

What condition does NCT05198141 study?

NCT05198141 studies Ectopic Pregnancy.

Is NCT05198141 still recruiting?

NCT05198141 is currently completed. Last updated 20 January 2022.

Last reviewed 2022-01-20 · How we verify

NCT05198141: letrezole

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Different Doses of Letrozole in Ectopic Pregnancy

Completed Phase 4 Last updated 20 January 2022

What this trial tests

Phase 4 trial testing Letrozole tablets in Ectopic Pregnancy in 60 participants. Completed in 1 January 2022.

Timeline

15 December 2020

Primary endpoint
20 November 2021

1 January 2022

Quick facts

Lead sponsor	Zagazig University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	15 December 2020
Primary completion	20 November 2021
Estimated completion	1 January 2022
Sites	1 location across Egypt

Drugs / interventions tested

Letrozole tablets — full drug profile →
laparoscopic salpingectomy

Conditions studied

Ectopic Pregnancy — all drugs for Ectopic Pregnancy →

Sponsor

Zagazig University

Who can join

Adults 19 to 35, female only, with Ectopic Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The utilization of letrozole at a daily dose of 10 mg for medical treatment of ectopic pregnancy considerably has a high success rate without imposing any serious side effects compared to daily 5mg letrozole.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Letrozole tablets

Trials testing the same drug.

NCT06861803 — Laboratory and Ultrasound Findings and Response to Letrozole in PCOS Patients · not yet recruiting
NCT06354439 — Use of Letrozole for Ectopic Pregnancy · Phase 4 · recruiting
NCT07168837 — Letrozole and Cabergoline Versus Letrozole Alone in Ovulation Induction · NA · completed
NCT06367712 — Letrozole Alone Protocol Versus Using Letrozole and HCG Protocol · Phase 1 · completed
NCT05601700 — Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial) · Phase 3 · recruiting

Other recruiting trials for Ectopic Pregnancy

Currently open trials in the same condition.

NCT07306689 — Posttraumatic Stress Disorder in Ectopic Pregnancy · recruiting
NCT07057115 — Comparison of vNOTES and Laparoscopic Salpingectomy in the Surgical Treatment of Ectopic Pregnancy · NA · recruiting
NCT06615843 — Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up · NA · recruiting
NCT07186127 — Methotrexate Treatment in Cases of Ectopic Pregnancy With Relative Contraindications · recruiting
NCT06471166 — The Effect of Different Treatment Modalities of Tubal Ectopic Pregnancy on Ovarian Reserve: a Prospective Cohort Study · recruiting

Other Zagazig University trials

Trials by the same sponsor.

NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05198141 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zagazig University
Last refreshed: 20 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05198141.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing